{
  "id": 12769742,
  "title": "As Temasek, TPG, KKR fuel an acquisition spree, this eye-care chain is betting on something different",
  "url": "https://urgent.news/2026/10/08/as-temasek-tpg-kkr-fuel-an-acquisition-spree-this-eye-care-chain-is",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-08T02:30:07.000Z",
  "source": {
    "name": "The Ken",
    "slug": "the-ken",
    "url": "https://the-ken.com/story/as-temasek-tpg-kkr-fuel-an-acquisition-spree-this-eye-care-chain-is-betting-on-something-different/"
  },
  "original_language": "en",
  "account": "In October 2025, The Eye Foundation, a 40-year-old eye-care chain based in Coimbatore, raised Rs 650 crore for a 20% stake in the company from Verlinvest, a consumer-brands-and-retail VC fund. This investment decision was unusual for the sector, as most competitors opted for healthcare-focused private-equity funds such as Temasek, Blackstone, TPG, and KKR. Verlinvest, which has backed companies like Epigamia, Wakefit, and Purplle, valued the company at a similar level to its competitors and offered a more favorable valuation than the latest fundraise led by Dr Agarwal. In FY27, The Eye Foundation anticipates a nearly 90% year-on-year revenue growth, reaching Rs 550 crore. The company's Ebitda margin has consistently remained above 30%, a rare achievement in the healthcare sector.",
  "summary": "The post As Temasek, TPG, KKR fuel an acquisition spree, this eye-care chain is betting on something different appeared first on The Ken .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}